Indonesia Kidney Cancer Therapeutics Market Analysis

Indonesia Kidney Cancer Therapeutics Market Analysis


$ 3999

The Indonesia Kidney Cancer Therapeutics Market was valued at $37.74 Mn in 2023 and is predicted to grow at a CAGR of 4.86% from 2023 to 2030, to $52.61 Mn by 2030. The key drivers of this industry include the rising incidence of kidney cancer, advancements in treatment options, and the growing aging population. The industry is primarily dominated by players such as AstraZeneca, Pfizer, Novartis, and Merck among others.

CATEGORY: Pharmaceuticals GEOGRAPHY: Indonesia AUTHOR: Aashwi Mehta

Buy Now

Indonesia Kidney Cancer Therapeutics Market Executive Summary

The Indonesia Kidney Cancer Therapeutics Market was valued at $37.74 Mn in 2023 and is predicted to grow at a CAGR of 4.86% from 2023 to 2030, to $52.61 Mn by 2030.

Kidney cancer refers to the abnormal proliferation of cells in the kidney tissue. A tumor is a mass that develops from these cells over time. Hematuria, a lump or mass in the kidney area, fatigue, anemia, loss of appetite, and flank pain are some of the symptoms. Renal Cell Carcinoma (RCC) is the most common type of kidney cancer. Other types include transitional cell carcinoma, Wilms tumor, and renal sarcoma. Several risk factors contributing to kidney cancer can be further divided into modifiable and non-modifiable factors. Smoking and Obesity are the two major modifiable factors responsible for kidney disease, whereas age and gender are the non-modifiable ones.

Overall, renal cancer is more prevalent in males than females, with a sex ratio of 2.3:1. The most frequent age group is 51–65 years. Most of the kidney cases reported are also at an advanced stage. This data highlights the significant impact of kidney and renal pelvis cancer on both men and women in Indonesia. The market is driven by significant factors like the rising incidence of kidney cancer, advancements in treatment options, and the growing aging population. However, stringent regulatory processes, higher costs, and side effects related to treatment restrict the growth and potential of the market.

Prominent players in this field include AstraZeneca, Pfizer, Novartis, Merck, Bayer, Roche, Abbott, Sanofi, Teva Pharmaceuticals, and Takeda Pharmaceutical.

Indonesia Kidney Cancer Therapeutics Market Report 2030 to 2030

Market Dynamics

Market Growth Drivers

Rising incidence of Kidney cancer: There is an estimated 2,676 new cases of kidney cancer in Indonesia. As new and better treatments are sought to meet this urgent medical need, Indonesia's renal cancer therapeutics market is expected to rise significantly due to the high incidence and mortality, which drives demand for advanced renal cancer therapeutics.

Advancements in treatment options: The introduction of targeted treatments, and immunotherapies, among other recent developments, is greatly expanding the range of available treatment options and improving patient outcomes. Because of these developments, there is a greater need for advanced therapies, which propels the market, providing pharmaceutical companies with a great chance of meeting the increasing need for indicated therapies.

Growing Aging Population: With an average annual growth rate of 1.52%, the population of Indonesia aged 65 and over increased from 3.4% in 1974 to 7% in 2023. Given that an aging population raises the incidence of renal cancer and consequently increases demand for related treatments, this demographic shift is a major market driver for Indonesia's renal cancer therapeutics market.

Market Restraints

Stringent Regulatory Process: A medicine must receive marketing authorization from Badan Pengawas Obat dan Makanan (Badan POM/BPOM), also known as the Indonesian Food and Drug Administration to enter the Indonesian pharmaceutical market. The market for renal cancer therapeutics is constrained by this regulatory requirement because of the possible intricacies and length of time associated with the licensing procedure.

High Cost of Treatment: Cancer imposes a significant economic burden on patients, their families, and healthcare providers in Indonesia. The high out-of-pocket (OOP) costs for specialized treatment and therapy, which are not fully covered by the National Health Insurance, impact household expenditure, posing a restraint on the renal cancer therapeutics market.

Side Effects of Treatment: Side effects from kidney cancer treatments represent a major market restraint. These negative effects may limit the use of specific therapies and decrease patient compliance, which may affect the overall efficacy of those therapies. Renal cancer therapeutic market growth and innovation are hampered by patients' and healthcare providers' reluctance to embrace novel treatments due to the possibility of severe adverse effects.

Regulatory Landscape and Reimbursement Scenario

Under the authority of the Indonesian Ministry of Health (MOH), The Indonesian Food and Drug Administration, or Badan Pengawas Obat dan Makanan (Badan POM/BPOM), is in charge of enforcing local laws pertaining to pharmaceuticals and medical devices. Manufacturers must successfully negotiate a variety of intricate regulatory processes, including registration requirements, market authorizations, and regulatory requirements, to gain entry to the market. Indonesia also has a mandatory health insurance program called Jaminan Kesehatan Nasional (JKN) which is designed to make basic medical care and facilities available to all citizens.

Competitive Landscape

Key Players

Here are some of the major key players in the Indonesia Kidney Cancer Therapeutic Market:

  • AstraZeneca
  • Pfizer
  • Novartis
  • Merck
  • Bayer
  • Roche
  • Abbott
  • Sanofi
  • Teva Pharmaceuticals
  • Takeda Pharmaceutical

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Indonesia Kidney Cancer Therapeutics Market Segmentation

By Cancer Type

  • Wilms tumor
  • Clear Cell Renal Carcinoma
  • Transitional Cell Carcinoma
  • Others

By Treatment

  • Targeted Therapy
  • Immunotherapy
  • Radiation Therapy
  • Surgeries

By End Users

  • Hospitals
  • Specialty Centers
  • Ambulatory Surgical Centers

By Distribution Channel

  • Hospital-based pharmacies
  • Retail pharmacies
  • Online pharmacies

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 27 June 2024
Updated by: Shivam Zalke

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up